Transdermal drug delivery device having enhanced adhesion

Details Transdermal drug delivery device having enhanced adhesion Transdermal drug delivery device having enhanced adhesion

1996-08-15

1998-11-24

Brouillette, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424447, 424449, A61F 1302

Patent

active

058403272

ABSTRACT:
A device for the transdermal administration of a drug to a sensitive body area such as the scrotum. Devices according to the invention provide an improved quality of adhesion to the body area while also providing patient comfort during use and upon removal of the device. Also disclosed are methods of transdermal delivery such as the transcrotal delivery of testosterone to hypogonadic males.

REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3731683 (1973-05-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4314557 (1982-02-01), Chandrasekaran
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4435180 (1984-03-01), Leeper
patent: 4559222 (1985-12-01), Enscore et al.
patent: 4568343 (1986-02-01), Leeper et al.
patent: 4573999 (1986-03-01), Netto
patent: 4588580 (1986-05-01), Gale et al.
patent: 4645502 (1987-02-01), Gale et al.
patent: 4661099 (1987-04-01), Von Bittera
patent: 4699792 (1987-10-01), Nick et al.
patent: 4704282 (1987-11-01), Campbell et al.
patent: 4711781 (1987-12-01), Nick et al.
patent: 4725439 (1988-02-01), Campbell et al.
patent: 4743249 (1988-05-01), Loveland
patent: 4816258 (1989-03-01), Nedberge et al.
patent: 4849226 (1989-07-01), Gale
patent: 4867982 (1989-09-01), Campbell et al.
patent: 4904475 (1990-02-01), Gale et al.
patent: 4908027 (1990-03-01), Enscore et al.
patent: 4938759 (1990-07-01), Enscore et al.
patent: 4943435 (1990-07-01), Baker et al.
patent: 5004610 (1991-04-01), Osborne et al.
patent: 5132115 (1992-07-01), Wolter et al.
patent: 5462743 (1995-10-01), Turner
Black "Transdermal Drug Delivery Systems", US Pharmacist, Nov. 1982, pp. 49-78.
Arita, et al., "Studies on Percutaneous Absorption of Drugs", Chem. Phar. Bull., vol. 18, 1970, pp. 1045-1049.
Idson, "Percutaneous Absorption", J. Phar. Sci., vol. 64, No. 6, pp. 910-922, 1975.
Clooney, Advances in Biomedical Engineering, Part 1, Chapter 6, "Drug Permeation Through Skin: Controlled delivery for Topical or Systemic Therapy", Marcel Dekker, Inc., New York, and Basel, 1980, pp. 305-318.
J. DeBoever et al., Variation of Progesterone, 20 .alpha.-Dihydroprogesterone and Oestradiol Concentration in Human Mammary Tissue and Blood after Topical Administration of Progesterone, Percutaneous Absorption of Steroids, Academic Press, New York, pp. 259-265 (1980).
R. Sitruk-Ware et al., Treatment of Benign Breast Diseases by Progesterone Applied Topically, pp. 219-229, Percutaneous Absorption of Steroids, Academic Press, New York, (1980).
Chandrasekaran, Advances in Biomedical Engineering, Part 1, Chapter 6, "Drug Permeation Through Skin: Controlled delivery for Topical or Systemic Therapy", Marcel Dekker, Inc., New York and Basel, 1980, pp. 305-318.

Affiliated with

Also associated with

Rating

Transdermal drug delivery device having enhanced adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal drug delivery device having enhanced adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal drug delivery device having enhanced adhesion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1699371